JP Morgan maintains Alignment Healthcare at Overweight, lowers price target to $8 from $10
JP Morgan kept Alignment Healthcare at Overweight but reduced its price target to $8 from $10, a 20% cut. The new target suggests a 10% upside from the Oct 30 close of $7.27. Recent analyst price targets for the company range from $9 to $12.
How this was made

The 30-second read
Why it matters
A 20% target cut may prompt short interest or sell pressure, but the effect is limited to the micro‑cap.
Market read
Analyst target change provides modest new information for traders of ALHC.
Timing
today
Background
The article reports a recent analyst action by JP Morgan on Alignment Healthcare.
Ticker impact
JP Morgan lowered its price target for Alignment Healthcare to $8 from $10, indicating a 20% reduction.
likely downward pressure as investors price in the lower target
Target reduction is a fresh analyst action, but no new operational data accompanies it.
Key entities
- companyAlignment Healthcare
Micro‑cap healthcare firm covered by JP Morgan.




